Cases & Deals

GRA Venture Fund participates in $25 million Series A financing round of Antios Therapeutics

Clients GRA Venture Fund, LLC and GRA Venture Fund (T.E.), LLC

Jones Day represented GRA Venture Fund in connection with its participation in the $25 million Series A financing round of Antios Therapeutics Inc., an Atlanta, Georgia-based biopharmaceutical company focused on the development of novel antiviral therapies for unmet medical needs.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.